Foghorn Therapeutics Inc. Quarterly Common Stock, Shares, Issued from Q4 2019 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Foghorn Therapeutics Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2019 to Q3 2024.
  • Foghorn Therapeutics Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 55.6M shares, a 31.7% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 55.6M +13.4M +31.7% Sep 30, 2024 10-Q 2024-11-04
Q2 2024 55.3M +13.5M +32.2% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 42.6M +761K +1.82% Mar 31, 2024 10-Q 2024-05-06
Q4 2023 42.3M +479K +1.15% Dec 31, 2023 10-Q 2024-11-04
Q3 2023 42.2M +418K +1% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 41.9M +225K +0.54% Jun 30, 2023 10-Q 2023-08-04
Q1 2023 41.8M +395K +0.95% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 41.8M +504K +1.22% Dec 31, 2022 10-K 2024-03-07
Q3 2022 41.8M +4.75M +12.8% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 41.6M +4.77M +12.9% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 41.4M +4.6M +12.5% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 41.3M +4.51M +12.3% Dec 31, 2021 10-K 2023-03-09
Q3 2021 37M +30.8M +493% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 36.9M Jun 30, 2021 10-Q 2021-08-10
Q1 2021 36.8M Mar 31, 2021 10-Q 2021-05-11
Q4 2020 36.8M +31M +538% Dec 31, 2020 10-K/A 2022-08-09
Q3 2020 6.24M Sep 30, 2020 10-Q 2020-12-04
Q4 2019 5.76M Dec 31, 2019 10-K 2021-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.